These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 13068376)

  • 21. Inhibition of hyaluronidase by urinary kallikrein.
    WARREN GH; SEIFTER J; GLASSMAN JM
    Nature; 1962 May; 194():770-1. PubMed ID: 14005031
    [No Abstract]   [Full Text] [Related]  

  • 22. Critical evaluation of the fibrin plate method for estimating fibrinolytic enzymes and activators.
    AUERSWALD W; DOLESCHEL W
    Thromb Diath Haemorrh; 1960 Oct; 5():112-20. PubMed ID: 13685088
    [No Abstract]   [Full Text] [Related]  

  • 23. Response of frog body water to posterior pituitary extract and hyaluronidase.
    VARTIAINEN O; VENHO EV; ECKERT D
    Ann Med Exp Biol Fenn; 1951; 29(1):69-74. PubMed ID: 14915197
    [No Abstract]   [Full Text] [Related]  

  • 24. Report of tissue plasminogen activator (tPA) injection in a very low dose for the treatment of posttrabeculectomy fibrin.
    Burnstein Y; Higginbotham EJ
    J Glaucoma; 1998 Oct; 7(5):361. PubMed ID: 9786567
    [No Abstract]   [Full Text] [Related]  

  • 25. The effects of continuous local injection of hyaluronidase on skin and subcutaneous tissue in rats.
    WILLIAMS RG
    Anat Rec; 1955 Jul; 122(3):349-61. PubMed ID: 13249097
    [No Abstract]   [Full Text] [Related]  

  • 26. [On fibrinolytic factors contained in the urine. I. Behavior in normal individuals].
    SABBADINI E; STOPPANI L; ZILIOLI E
    Arch Sci Med (Torino); 1961 Nov; 112():352-6. PubMed ID: 14495774
    [No Abstract]   [Full Text] [Related]  

  • 27. Reconstitution of the dermal barrier to fluid diffusion following administration of hyaluronidase.
    HECHTER O
    Proc Soc Exp Biol Med; 1948 Mar; 67(3):343. PubMed ID: 18910631
    [No Abstract]   [Full Text] [Related]  

  • 28. [Permeability studies with colloids. On the renal excretion of polyvinylpyrrolidon after intraperitoneal and subcutaneous infusion without and with hyaluronidase].
    SCHUBERT R; WOERNER H
    Z Gesamte Exp Med; 1959; 132():234-46. PubMed ID: 14443677
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary hyaluronidase.
    BERLYNE GM
    Nature; 1960 Feb; 185():389-90. PubMed ID: 13799570
    [No Abstract]   [Full Text] [Related]  

  • 30. [Blood levels of a broad-spectrum antibiotic following its intramuscular administration with and without hyaluronidase. Experimental study].
    Pannuti F
    G Mal Infett Parassit; 1966 Jul; 18(7):486-91. PubMed ID: 5990246
    [No Abstract]   [Full Text] [Related]  

  • 31. [Fractionated analysis of tissue juice. II. Volume, cell content and potassium level of the tissue juice, with reference to the effect of hyaluronidase].
    BARTELHEIMER H; STEINORTH G; OLK W
    Z Gesamte Exp Med; 1951; 118(2):109-22. PubMed ID: 13029633
    [No Abstract]   [Full Text] [Related]  

  • 32. The effect of hyaluronidase injection on the vitreous humour of the rabbit.
    PIRIE A
    Br J Ophthalmol; 1949 Nov; 33(11):678-84. PubMed ID: 15392448
    [No Abstract]   [Full Text] [Related]  

  • 33. The Kinetics of Reversible Hyaluronic Acid Filler Injection Treated With Hyaluronidase.
    Juhász MLW; Levin MK; Marmur ES
    Dermatol Surg; 2017 Jun; 43(6):841-847. PubMed ID: 28498207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of hyaluronidase on oxalic acid loading of healthy and calculous kidneys].
    KEUTEL HJ; SPEICHER H
    Urol Int; 1960; 10():244-52. PubMed ID: 13752804
    [No Abstract]   [Full Text] [Related]  

  • 35. Degradation of Hylauronic Acid Fillers Using Hyaluronidase in an In Vivo Model.
    Ferraz RM; Sandkvist U; Lundgren B
    J Drugs Dermatol; 2018 May; 17(5):548-553. PubMed ID: 29742187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of heparin and a covalently-linked antithrombin-heparin complex with components of the fibrinolytic system.
    Chander A; Atkinson HM; Stevic I; Berry LR; Kim PY; Chan AK
    Thromb Haemost; 2013 Dec; 110(6):1180-8. PubMed ID: 24048327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between urinary hyaluronidase and diuresis.
    GINETZINSKY AG
    Nature; 1961 Jan; 189():235-7. PubMed ID: 13705483
    [No Abstract]   [Full Text] [Related]  

  • 38. [Antiedemic action of hyaluronidase when amphotericin B is administered].
    Dumova AM; Etingova NI; Slonitskaia NN; Lagert IK; Mikhaĭlets GA
    Antibiotiki; 1973 Jun; 18(6):537-41. PubMed ID: 4778258
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of large doses of hyaluronidase upon urine concentration in dogs.
    Rosenfeld JB; Hirata K; Brest AN; Moyer JH
    Isr J Med Sci; 1967; 3(1):119-30. PubMed ID: 6047690
    [No Abstract]   [Full Text] [Related]  

  • 40. The fibrinolytic activity of urine.
    WILLIAMS JR
    Br J Exp Pathol; 1951 Dec; 32(6):530-7. PubMed ID: 14895792
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.